Longevity by Design: The Science Behind Healthy Aging

Date

May 19 2026

Time

12:30 am - 2:00 pm

Labels

Main Event

Location

Pavilion 15 Thessaloniki International Fair
Pavilion 15 Thessaloniki International Fair
Egnatias 154, TIF, Thessaloniki 546 36
Website
https://thessalonikifair.gr/el

Modern longevity science is advancing faster than ever, paving the way for a new era of prevention, proactive health management, and personalized medicine. This panel explores how biotechnology, aging biomarkers, genomics, and computational biology are driving the shift from “treating disease” to “slowing aging.” Speakers will discuss practical applications, emerging breakthroughs, and the ethical dilemmas surrounding lifespan extension, offering a comprehensive view of how technology is fundamentally reshaping human health.

Who the
Speakers are:

Speakers

  • Evi Chatzianandreou
    Evi Chatzianandreou
    Scientific Director at the Nao Longevity Hub of Bluegr Hotels

    Evi Chatzianandreou, a member of the Healthy Longevity Medicine Society and a co-founding member of the Hellenic Institute for Healthy Longevity, is Scientific Director at the Nao Longevity Hub of Bluegr Hotels. She is a graduate of the Athens Medical School and holds postgraduate degrees (Master’s and PhD) in Public Health (Epidemiology and Health Policy and Management) from the Harvard T.H. Chan School of Public Health.

    She has worked across a wide spectrum of the health sector—health policy, health insurance and care, health service delivery, and management—in the United States, the United Kingdom, and Greece, in the public and private sectors as well as in non-profit organizations. Her professional experience includes senior positions at the Ministry of Health (Center for Disease Control and Prevention) and the U.S. Congress, as well as roles in multinational and Greek companies. She also served as Director of the Health and Healthcare Studies Division at the international organization RAND Europe, part of the RAND Corporation.

    She was a Fellow of the American Association for the Advancement of Science (AAAS), a Lecturer at the Harvard School of Public Health, and a Visiting Professor at the School of Public and Environmental Affairs at Indiana University. She has published studies in international journals on prevention, management, and the economic evaluation of health programs and services.

    From 2000 to 2003, she served as Deputy Governor of IKA with responsibility for the health sector, and from 2009 to 2012 as Advisor to the Ministry of Education on Research, Technology, and Innovation. She has also served as Scientific Advisor to the Big Pi Venture Capital Fund and is an Associate Professor at Hellenic American University.

  • Dimitrios P. Vlachakis
    Dimitrios P. Vlachakis
    Associate Professor of Genetics at the Genetics Laboratory of the Department of Biotechnology, School of Applied Biology and Biotechnology, Agricultural University of Athens

    Dr. Dimitrios Vlahakis (MSc, MPhil, PhD, MGS, FGS, MRSC, MRSB, MRSMed) is an Associate Professor of Genetics at the Genetics Laboratory of the Department of Biotechnology, School of Applied Biology and Biotechnology, Agricultural University of Athens. He completed his doctoral and postdoctoral studies in Greece, Wales, and the United States, specializing in Drug Design, Medicinal Chemistry, and Precision Medicine for human diseases.

    He is a Senior Researcher (Grade A) and Research Director at the Unit of Genetics and Medical Genetics of the Research University Institute of Maternal and Child Health and Precision Medicine, Medical School of Athens, National and Kapodistrian University of Athens. Dr. Vlahakis was recently elected Visiting Full Professor with an honorary title (Honorary Professor) in Genetics and Medical AI at the Centre for Craniofacial and Regenerative Biology, Faculty of Dentistry, Oral & Craniofacial Sciences, King’s College London, United Kingdom.

    Furthermore, Dr. Vlahakis serves as Vice Chair of the Committee for the Evaluation and Reimbursement of Medicinal Products for Human Use (HTA – Health Technology Assessment) at the National Organization for Medicines (EOF), Ministry of Health, and has been appointed Alternate National Representative to the European Union Health Technology Assessment (HTA) Network.

    His research output is extensive, with more than 200 original research articles published in high-impact international scientific journals (e.g., Science [AAAS], Cell Press, Nature Publishing Group). He has served as coordinator or principal investigator in more than 15 national and international research projects in personalized medicine and the design of novel diagnostic and therapeutic protocols. Finally, as a faculty member and supervisor, he has trained numerous students from the undergraduate to doctoral and postdoctoral levels, many of whom already hold prominent scientific positions in Greece and abroad.

  • George P. Chrousos
    George P. Chrousos
    Emeritus Professor of Pediatrics and Endocrinology, University of Athens

    Dr. George P. Chrousos is Professor of Pediatrics and Endocrinology Emeritus, Holder, UNESCO Chair on Adolescent Health Care, Director of the University Research Institute on Maternal and Child Health and Precision Medicine at the University of Athens, and President of the Hellenic Pasteur Institute. Professor Chrousos pioneered studies that elucidated the effects of stress on the organism at the behavioral, neuroendocrine, cellular, and molecular levels. He has also performed seminal research on human development, especially of the years of puberty and adolescence. He has received numerous major awards, including the Bodossaki Prize of Greece, the Fred Conrad Koch Award, the highest honor of the US Endocrine Society, as well as the Transatlantic Alliance Award of both the US Endocrine Society and The European Society of Endocrinology. He is an elected member of the Academia Europaea, the US National Academy of Medicine and the Academy of Athens. He has been included in the top 100 cited physician-scientists in the world and is the most cited pediatrician or endocrinologist internationally. Citations > 218.000, IF >220

  • Vassilis G Gorgoulis
    Vassilis G Gorgoulis
    Director of the Department of Histology–Embryology, Faculty of Medicine, National Kapodistrian University of Athens

    Professor Gorgoulis is a molecular pathologist (https://www.gorgoulis.gr/). He is the Director of the Department of Histology–Embryology, Faculty of Medicine, National Kapodistrian University of Athens, Greece. He is also Chair of Clinical Molecular Pathology at the Ninewells Hospital and Medical School, University of Dundee, UK; Adjunct Professor at the Biomedical Research Foundation, Academy of Athens; Honorary Professor at the Faculty Institute for Cancer Sciences, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, UK; and an elected member of the European Molecular Biology Organization (EMBO).
    Prof Gorgoulis’ research is focused on how cells react to oncogenic insults in order to preserve their homeostasis. His work is published in prestigious, highly-impacted peer reviewed journals that received >51.000 citations. He is recognized for proposing the “Oncogene-induced DNA damage model for cancer development” that led to the establishment of Genomic Instability, Replication Stress and Senescence as hallmarks of cancer. Within this context he also pioneered in developing innovative senoprobes that are included in the international guidelines for senescence detection as well as highly specific senolytic platforms for selective elimination of these cells.